Mr. Dean Burns reports

OCUMETICS WEBINAR - DISCUSSION OF ONE-MONTH POSTOPERATIVE PATIENT RESULTS

Ocumetics Technology Corp. is holding a webinar to discuss the one-month patient results for its initial group 1 patients who received the Ocumetics accommodating intraocular lens.

Webinar details are as follows.

Date:  Thursday, Oct. 15, 2025

Time:  6 p.m. ET

Join Ocumetics director and chief executive officer Dean Burns for an exclusive webinar covering important updates on its first-in-human study and what lies ahead.

Topics will include:

1. Discussion of one-month postoperative patient results and observations from the FIH study;
2. Next steps to complete the Ocumetics FIH study;
3. Live question-and-answer session with Dean Burns.

This is a timely opportunity to gain insight into Ocumetics's progress at this critical stage of development. Reserve your spot.

About Ocumetics Technology Corp.

Ocumetics is a Canadian research and product development company that is dedicated to developing advanced vision correction solutions that enhance the quality of life for patients. Through innovative research and development, Ocumetics aims to transform the field of ophthalmology with state-of-the-art intraocular lenses and other vision-enhancing technologies.

Ocumetics is in the first-in-human early feasibility study phase of a game-changing technology for the ophthalmic industry. Ocumetics has developed an intraocular lens that fits within the natural lens compartment of the eye, potentially to eliminate the need for corrective lenses. It is designed to allow the eye's natural muscle activity to shift focus from distance to near, providing clear vision at all distances without the help of glasses or contact lenses.

We seek Safe Harbor.